Greater Cannabis Company (GCAN) Gross Margin (2017 - 2021)
Greater Cannabis Company's (GCAN) quarterly Gross Margin came in at 0.2% in Q2 2021, down 10.0% year-on-year from 0.22% in Q2 2020, and down 106.74% quarter-over-quarter from 0.1% in Q2 2020.
Greater Cannabis Company (GCAN) Gross Margin (2017 - 2021) Analysis & Trends
Greater Cannabis Company's Gross Margin history runs 5 years deep, the most recent figure standing at 0.2% for Q2 2021.
- On a quarterly basis, Gross Margin fell 10.0% year-over-year to 0.2% in Q2 2021; TTM through Dec 2021 was 0.2%, a 273.0% decrease from a year earlier, with the FY2021 full-year figure at 0.2%, down 10.0% from the prior year.
- Gross Margin declined to 0.2% in Q2 2021 per GCAN's latest filing, from 0.1% in the prior quarter.
- Across five years, Gross Margin topped out at 100.0% in Q1 2018 and bottomed at 856.45% in Q3 2019.
- The 5-year median for Gross Margin is 35.83% (2017), against an average of 71.42%.
- Across the five-year window, Gross Margin surged 2117 bps in 2018 and dropped 10 bps in 2021, its largest moves.
- Year by year, Gross Margin stood at 51.47% in 2017, then grew by 21 bps to 62.26% in 2018, then sank by 51 bps to 30.56% in 2019, then tumbled by 100 bps to 0.1% in 2020, then tumbled by 107 bps to 0.2% in 2021.
- Per Business Quant, the three latest GCAN Gross Margin figures stand at 0.2% (Q2 2021), 0.1% (Q2 2020), and 30.56% (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -0.20% |
| Jun 30, 2020 | -0.10% |
| Dec 31, 2019 | 30.56% |
| Sep 30, 2019 | -856.45% |
| Jun 30, 2018 | 62.26% |
| Mar 31, 2018 | 100.00% |
| Sep 30, 2017 | 51.47% |
| Jun 30, 2017 | 41.10% |